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artifactual labeling of other axonal pop-
ulations. Thus, for future studies, the
most prudent approach will be to carry
out injections at some time after spinal
cord injury. Theminimal delay required
remains to be defined.
Experimental Procedures
Experimental Animals
Our repeat of the study by Kim et al. (2003)
used 8- to 10-week-old Nogo knockout mice
(the gene trap mutant that was generously
provided by these authors) and littermate
controls obtained by backcrossing homozy-
gous knockout mice to C57BL/6 mice. Young
adult (8- to 10-week-old) female mice of the
C57BL/6 strain were used in the experiment
that involved direct injections of BDA into the
cerebral ventricle. Histological procedures
were identical to those described in our previ-
ous study (Zheng et al., 2003), except as noted
above (for details, see the Supplemental
Experimental Procedures).
To determine the pattern of labeling that re-
sults when BDA is present in the cerebrospinal
fluid (CSF), five female C57BL/6 control mice
received dorsal hemisection injuries as above,
and then BDA was injected directly into the
cerebral ventricle underlying the sensorimotor
cortex. For this purpose, the Hamilton micro-
syringe was inserted to a depth of 2 mm at
a point 1 mm lateral to bregma, and 0.5 ml of
BDA was delivered. Mice were allowed to
survive for 17 days following the spinal cord
injuries/injections. A second group of five
mice received intraventricular BDA injections
and were allowed to survive for 3 days.
Histological methods were identical to our
previous study (Zheng et al., 2003). For
detailed procedures, see the Supplemental
Experimental Procedures.
Supplemental Data
The Supplemental Data for this article can
be found online at http://www.neuron.org/cgi/
content/full/54/2/191/DC1/.
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DOI 10.1016/j.neuron.2007.04.005Numerous in vivo pharmacological
studies have demonstrated the benefi-
cial effects of interfering with Nogo/
NgR function for axonal growth and
functional recovery after experimental
spinal cord injury (Bregman et al.,
1995; Brosamle et al., 2000; Fouad
et al., 2004; GrandPre et al., 2002; Ji
et al., 2005; Li et al., 2004, 2005; Li
and Strittmatter, 2003; Schnell and
Schwab, 1990; Wang et al., 2006).
Similar benefits are noted for stroke re-
covery (Lee et al., 2004; Papadopou-
los et al., 2002; Seymour et al., 2005).
However, genetic analysis of nogoand ngr has proven inconclusive
(Woolf, 2003). Two mouse lines, here
termed nogo-abtrap/trap (Kim et al.,
2003) and nogo-aEIII/EIII (Dimou et al.,
2006; Simonen et al., 2003), show en-
hanced growth of corticospinal (CST)
axons after dorsal hemisection. In
contrast, another line, here termed
nogo-abatg/atg (Zheng et al., 2003), fails
to show a regenerative phenotype.
Common to each of these studies
was the observation that myelin pre-
pared from mutant mice was signifi-
cantly less inhibitory to neurite out-
growth in vitro. Among the factorsNeuron 5that might explain the varied in vivo
outcomes are age at the time of lesion,
mouse strain background, surgical
techniques, axonal tracing methodol-
ogy, and the nature of the mutant
allele (Woolf, 2003). A follow-up study
demonstrated that the penetrance
of the nogo-aEIII/EIII phenotype for
CST axonal regeneration depends on
strain background (Dimou et al.,
2006). Regenerative axon growth is
quite prominent on the Sv129 strain
background, as compared to a mixed
or C57BL/6 background (Dimou
et al., 2006).4, April 19, 2007 ª2007 Elsevier Inc. 195
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Methodology
In theirCorrespondence,Steward et al.
present evidence that inaccurate injec-
tions of the axonal tracer biotin dextran
amine (BDA) can produce erroneous
labeling after spinal cord injury. They
show that BDA in the CSF shortly after
a spinal hemisection can label fibers in
the caudal white matter of the cord, ir-
respective of genotype. Mislabeled fi-
bers were distinguished by their large
diameter, their enrichment in ventrolat-
eral whitematter, their linear trajectory,
and their hollow appearance. This pat-
tern occurred in one of their original co-
hort of mice (Zheng et al., 2003) and
with much greater frequency subse-
quently. The second study utilized
deeper injections into the cerebral cor-
tex, injections that, in retrospect, are
likely to havepenetrated the ventricular
wall. Since similar spinal labeling oc-
curred after intentional ventricular in-
jection of BDA, the authors conclude
that uptake from the CSF accounts
for the pattern.
Steward et al. suggest that the
nogo-abtrap/trap phenotype in our study
(Kim et al., 2003) is attributable to mis-
labeling. We are convinced that geno-
type-selective mistracing cannot fully
explain the observations. In our stud-
ies, the vast majority of nogo-abtrap/trap
mice show caudal CST fibers that bear
no resemblance to the thick, linear,
hollow, ventrolateral labeling pattern
of Steward et al. This is clear in Figures
5A, 5B, 6C, and 6E of Kim et al. (2003),
where CST axons are thin, tortuous,
and situated predominantly in gray
matter. We have now analyzed 58
adult nogo-abtrap/trap mice (of various
ages and strains) with dorsal hemisec-
tions and immediate BDA injection.
Thirty-five of these mice (60%) exhibit
thin, branched CST fibers extending
caudal to the lesion. These profiles
are clearly distinct from the thick, lin-
ear, hollow fibers seen in the Steward
et al. study. Additional high-quality
examples of clearly valid caudal CST
labeling from recent nogo-abtrap/trap
mice are provided in Figures 1B and
1C here. Only 3 of our 58 mice (5%)
had a pattern consistent with Steward
et al. We conclude that the phenome-
non they describe is rare when in-196 Neuron 54, April 19, 2007 ª2007 Ejections are targeted to the cerebral
cortex in our studies.
Steward et al.’s suggestion that our
observations are artifactual and that
there is no injury-enhanced CST
growth phenotype in nogo-abtrap/trap
mice is based primarily on the similar-
ity of fiber appearance in our Figures
4B and 6B (Kim et al., 2003) with the
CSF-dependent labeling of their
Correspondence. Figures 4B and 6B
derive from one particular mouse in
our original study that had fibers con-
sistent with Steward et al. It is possible
that the labeling in the transverse sec-
tions of Figures 4B and 6B occurred
via the mechanism suggested in the
Steward et al. manuscript. The origin
of labeling in these two panels has to
be considered uncertain in light of the
follow-up studies of Steward et al.
However, if the rare mice with such
a pattern are excluded from the axon
counts in Figures 4F and 6F (Kim
et al., 2003), the same statistically valid
conclusions remain. Specifically, after
omitting these rare mice, labeled CST
fibers outside of the DCST proper are
significantly (p % 0.05) increased in
the nogo-abtrap/trap mice on both sides
of the spinal cord, at a level 5 mm ros-
tral to the hemisection (as in Figure 4F).
Similarly, after exclusion, labeled CST
fibers in the caudal spinal cord with
a thin tortuous regenerative appear-
ance are significantly (p % 0.05)
increased in the nogo-abtrap/trap mice,
at a level 5 mm below the hemisection
(as in Figure 6F). While the inclusion of
potentially CSF-mislabeled fibers from
rare nogo-abtrap/trap mice may have in-
advertently overrepresented the regen-
erative growth in transverse sections,
the nogo-abtrap/trap population exhibits
injury-induced CST growth when such
mice are excluded from the analysis.
Of equal importance, it should be
noted that the rare BDA/CSF artifact
of Steward et al. is easily distinguished
and is not an issue in our analysis of
parasagittal sections; it complicates
observations only in transverse sections
from a small subset of mice (Figures
4B and 6B of Kim et al., 2003). This is
obvious in longitudinal sections from
one of the three nogo-abtrap/trap mice
that had the linear, hollow, thick fibers
on transverse sections (Figure 2F).lsevier Inc.While weakly labeled linear profiles
can be detected in white matter of
these parasagittal sections, they are
clearly distinguishable from the densely
stained varicose and tortuous regener-
ating CST fibers present in the same
mouse that are consistent with regen-
erated fibers (Steward et al., 2003).
Only the strongly stained, branching
CST fibers were included in our origi-
nal Figure 5. When the trajectories of
such regenerating fibers as in Figures
1B and 1C here and Figures 5A and
5B (Kim et al., 2003) are combined
from all spinal sections from one
mouse in camera lucida, the pattern
is as in our original Figures 5G–5K.
Overall, we thank Steward et al. for
exploring one potential artifact in
BDA axonal tracing. While the veracity
of tracing must be monitored, mis-
labeling cannot fully account for the
differences between nogo-abtrap/trap
mice and control mice. CST growth in
nogo-abtrap/trap mice is significantly
greater than in control animals, but it
is also very much less than complete,
as documented in our original Figures
5 and 6 and Figures 1B and 1C here.
Age Dependency of
Regenerative Phenotype
in nogo-abtrap/trap Mice
Our initial study of nogo-abtrap/trap
mice raised a question as to whether
age after sexual maturity might influ-
ence the degree of CST regenerative
axonal growth after spinal cord hemi-
section. Therefore, we examined T7
bilateral dorsal hemisection lesions in
8- versus 14-week-old nogo-ab+/trap
and nogo-abtrap/trap mice. All mice
had normal open field locomotor
scores prelesion (Figure 2A) and
showed flaccid hindlimb paralysis
after surgery. Eight-week-old nogo-
abtrap/trap recovered significantly
greater hindlimb function in compari-
son to heterozygote littermates (two-
way ANOVA, p % 0.05). Both groups
of 14-week-old mice recovered less
well than did the 8-week-old mice of
the same genotype. However, the rela-
tively improved outcome in nogo-
abtrap/trap mice as compared to nogo-
ab+/trap mice was maintained at 14
weeks of age. The magnitude of the
age effect was approximately as great
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CorrespondenceFigure 1. CST Axonal Tracing in Different nogo-a/b/ Mice after Dorsal Hemisection
(A) Parasagittal sections of thoracic spinal cord from five different nogo-abatg/atg mice. The CST is traced from BDA injections at the time of a dorsal
hemisection. Rostral is left, dorsal is up. There is no evidence of CST growth past the lesion.
(B) Sections from five different nogo-abtrap/trapmice. Thesemice were littermates of the mice in (A) and were lesioned, traced, and processed as in (A).
Note the evidence of CST fiber growth caudal to the lesion site.
(C) For each section in (B), the boxed region is magnified.
(D) Open field locomotor scores (BBB) were recorded 3–21 days after bilateral dorsal hemisection in nogo-abtrap/trap, nogo-abatg/atg, and mixed het-
erozygote nogo-abtrap/atg animals (n = 8/group). Two-way ANOVA revealed that nogo-abtrap/trap recovered significant hindlimb function in comparison
to nogoAtrap/atg and nogo-abtrap/atg (p < 0.05). All data are mean ± SEM.
(E) BDA-labeled CST axons were counted 1, 2, and 3 mm caudal from the epicenter of the lesion (denoted by asterisk). nogo-abtrap/trap had signif-
icantly more CST axons caudal to the lesion in comparison to nogo-abtrap/atg and nogo-abatg/atg animals (*p < 0.01; #p < 0.05; ANOVA, n = 8/group).
All data are mean ± SEM.
(F) Distinction between CST tracing and mislabeling in one mouse with both patterns. A parasagittal section of the thoracic spinal cord in a region
2–3 mm caudal to a dorsal hemisection is shown. This image is from the problematic mouse of Figures 4B and 6B in Kim et al. (2003). While BDA
labeling of the CST is evident as tortuous finely branched varicose fibers (arrows), weaker BDA labeling of the linear, thick, hollow type described
by Steward et al. is clearly distinct (arrowheads).Neuron 54, April 19, 2007 ª2007 Elsevier Inc. 197
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CorrespondenceFigure 2. Age Dependence of Regenerative Phenotype in nogo-abtrap/trap Mice
(A) Open field locomotor scores were recorded 3–21 days after dorsal hemisection in 8-week-old
nogo-ab+/trap, nogo-abtrap/trap, 14-week-old nogo-ab+/trap, and 14-week-old nogo-abtrap/trap mice.
Within each age group, there is significantly better walking in the nogo-abtrap/trap mice as com-
pared to the nogo-ab+/trap mice (p < 0.05; ANOVA, n = 12 per group). All data are mean ± SEM.
(B) Sagittal photomontage through the lesion site (denoted by asterisk) shows a typical example of
CST axon tracing after unilateral cortical BDA infusion in an 8-week-old nogo-abtrap/trap mouse.
Scale bar, 500 mm.
(C and D) High-magnification views of BDA-labeled CST fibers from (B) reveal contorted and var-
icose axonal profiles consistent with regenerated axons. Scale bar, 100 mm.
(E) Counts of BDA-labeled profiles observed 1–3mm caudal to the lesion site in the indicated mice
from micrographs as in (B). Axons caudal to the lesion site were observed more frequently in
8-week-old nogo-abtrap/trap mice than in 8-week-old nogo-ab+/trap, 14-week-old nogo-abtrap/trap,
or nogo-ab+/trap mice (*p < 0.05, t test). All data are mean ± SEM.
(F–I) Photomicrographs of transverse sections through the ventral horn show significantly greater
5HT-IR axon sprouting caudal to a dorsal hemisection in 8-week-old nogo-abtrap/trapmice (G) than
in 14-week-old nogo-abtrap/trap mice (H) or in nogo-ab+/trap littermates (I) ([F]; *p < 0.0005, t test).
The 14-week-old nogo-abtrap/trap mice exhibit a greater degree of caudal 5HT axon arbor than
do 14-week-old nogo-ab+/trap and 8-week-old nogo-ab+/trap mice ([F]; #p < 0.05, t test). Quantifi-
cation of axon density in the ventral horn rostral to the lesion shows no difference between age and
genotype groups (F). Scale bar, 200 mm. All data are mean ± SEM.198 Neuron 54, April 19, 2007 ª2007 Elsevier Inc.as the genotype effect, such that the
14-week-old nogo-abtrap/trapmice per-
formed indistinguishably from the 8-
week-old nogo-ab+/trap mice.
Axonal growth was assessed in
these mice via unilateral tracing of the
CST with BDA (Figures 2B–2E).
Labeled fibers can be seen as a fascic-
ulated bundle that is completely inter-
rupted by the lesion (Figure 2B). In
this group of 8-week-old nogo-
abtrap/trap mice, labeled axons are
detected more than 3 mm caudal to
the lesion and are significantly more
numerous in nogo-abtrap/trap mice
than in nogo-ab+/trap mice (Figure 2E,
replicating Kim et al., 2003). Again,
thecaudalBDA+axonshavea varicose
morphology, consistent with regener-
ated fibers (Figures 2C and 2D).
Regenerating CST axons are also ob-
served in 14-week-old nogo-abtrap/trap
mice, but are significantly less
frequent than in 8-week-old nogo-
abtrap/trap (Figures 2E). The sum of
CST axons observed caudal to the
lesion in 14-week-old nogo-abtrap/trap
mice is significantly greater from het-
erozygote littermates at 1 mm past
the lesion (Figure 2E). Axons of the
descending serotonergic raphespinal
system were also assessed in 8- and
14-week-old nogo-abtrap/trap and
nogo-ab+/trap injured mice (Figures
2F–2I). Rostral to the hemisection,
there is no significant difference in 5HT-
IR arborizations in the ventral horns of
8- and 14-week-old nogo-abtrap/trap
and nogo-ab+/trap mice (Figure 2F). In-
spection of transverse sections of the
lumbar spinal cord caudal to the lesion
revealed robust sprouting of 5HT-IR
fibers in the ventral horns of 8-week-
old nogo-abtrap/trap mice (Figure 2G).
The total length of 5HT-IR fibers is sig-
nificantly greater than in 14-week-old
nogo-abtrap/trap mice (Figure 2H) or
in 8-week-old nogo-ab+/trap mice
(Figure 2I). Thus, the age after sexual
maturity significantly modifies the re-
strictive effect of Nogo-A/B on axonal
growth and on functional recovery.
Different nogo-abMutant Alleles
Have Distinct Regenerative
Phenotypes
Since our findings indicate that
age modulates the nogo-abtrap/trap
Neuron 54, April 19, 2007 ª2007 Elsevier Inc. 199
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Correspondenceregenerative phenotype and since
strain background alters the pheno-
type (Dimou et al., 2006), the results re-
ported by different laboratories for
nogo-a/ mice might be caused by
mouse age, strain background, surgi-
cal technique, postoperative care,
axonal tracing method, or the nature
of the mutant allele. In order to isolate
the influence of different mutant alleles
from other factors, we obtained the
nogo-abatg/atg mice with the least re-
ported axonal growth (Zheng et al.,
2003) and interbred them with the
nogo-abtrap/trap mice with the greatest
reported axonal growth (Kim et al.,
2003). We completed dorsal hemi-
sections on mixed heterozygote
nogo-abtrap/atg, nogo-abtrap/trap, and
nogo-abatg/atg mice. All mice had nor-
mal hindlimb articulation presurgery
and flaccid hindlimb paralysis after
waking from anesthesia postsurgery.
In open field locomotion, nogo-
abtrap/trap mice recovered significantly
more hindlimb function than did
nogo-abtrap/atg and nogo-abatg/atg
mice (two-way ANOVA, p% 0.05, Fig-
ure 1D). There was no significant
difference in the BBB scores of nogo-
abtrap/atg versus nogo-abatg/atg mice.
BDA-labeled CST axons were
counted 1–3 mm caudal to the lesion.
Nogo-abtrap/trap mice (Figures 1B, 1C,
and 1E) have significantly more axons
caudal to the lesion in comparison
to nogo-abtrap/atg (Figure 1E) or nogo-
abatg/atg (Figures 1A and 1E) mice.
Thus, measures of CST regenerative
growth and locomotor BBB scores
yield similar patterns. We conclude
that the nature of the nogo mutant al-
lele has a significant effect on the SCI
phenotype when age, strain, surgeon,
behavioral paradigm, and tracing
method are held constant. The regen-
erative phenotype associated with
the nogo-abtrap allele is fully comple-
mented by the nogo-abatg allele and
is not dominant, even on a nogo-ab
null background.
Discussion
Strikingly, the studies here demon-
strate that different mutant nogo-ab
alleles produce distinct phenotypes
when other variables are controlled.
Even in the nogo-abtrap/trap mice, aminority of CST fibers exhibit long-
distance regenerative growth after
dorsal hemisection, and this percent-
age is modified by age. The molecular
basis for the variable penetrance of
a growth phenotype within one strain
and between two mutant alleles is not
yet clear. Both mutations eliminate de-
tectable Nogo-A protein, but preserve
brain nogo-c mRNA levels. Because
one mutant allele targets exon I and
the other targets exon III with a differ-
ent insertion, there may be different
effects on the nogo-c promotor or on
the expression of adjacent genes. In
considering the hypothesis that the ex-
pression of neighboring genes might
be altered by these mutations, we
have noted no alteration of brain ex-
pression for the six genes closest to
the nogo locus in RT-PCR studies
(data not shown). Since cell-type-
specific expression has not been
assessed, it remains possible that
there is differential low-level but com-
pensatory expression of Nogo-C or
a similarly sized isoform selectively in
oligodendrocytes. The nogo-abtrap/atg
mixed heterozygote phenotype
matches most closely the dorsal
hemisection phenotype of the nogo-
abatg/atg mice. The complementation
of the nogo-abtrap allele by the nogo-
abatg allele is consistent with hypomor-
phic expression of a Nogo protein in
oligodendrocytes. Incontrast, the hypo-
thesis that an amino-terminal protein
fragment derived from the nogo-abtrap
allele has a dominant proregenerative
effect on a Nogo-A null background
(Kim et al., 2003) is not supported by
the nogo-abtrap/atg phenotype.
Crucially, the existence of an allelic
difference between the nogo-abtrap
and nogo-abatg mice poses the ques-
tion of whether the nogo-abatg/atg
mice are devoid of enhanced injury-
induced axonal growth. Despite the
absence of a CST growth phenotype
after dorsal hemisection, the nogo-
abatg/atg mice of Zheng et al. (2003)
do show marked injury-induced CST
axonal growth after the more discrete
CNS lesion of pyramidotomy (Cafferty
and Strittmatter, 2006). Therefore, the
lack of CST growth in the nogo-
abatg/atgmice is relative, and not abso-
lute. Thus, strain, age, mutant allele,and lesion model all have an influence
on the adult CNS axonal growth
phenotype of mice lacking Nogo-A.
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